NIH-funded research R15 grant

Exploring how peptides behave in tiny spaces and respond to pH changes

Official title: Understanding and Designing pH-Responsive Peptides in Confined Nanoscale Environments

Funded at University of Massachusetts Lowell · NIH-10974635 · Data updated 2026-11-12

This study is looking at how tiny proteins behave when they're organized in specific ways, which could help create new sensors and treatments for diseases like cancer.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Lowell
NIH-funded
Lab location1 site (Lowell, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2027
Funding year2024
Award (this year)$455,940
NIH project number1R15GM155859-01
Project IDNIH-10974635 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with conditions that could benefit from advanced peptide-based therapies, particularly those related to cancer or metabolic disorders.

Less likely to help

Patients with conditions unrelated to peptide therapies or those not requiring pH-responsive treatments may not benefit from this research.

What this research studies

This research investigates how the confinement and organization of short biological peptides at the nanoscale can affect their behavior and properties. By focusing on intrinsically disordered proteins, which can change in response to environmental factors like pH, the project aims to develop new methods for creating responsive sensors and therapeutics. The researchers will study how these peptides interact with nanoparticles and how their properties can be controlled for potential medical applications. This work could lead to advancements in therapies for various diseases, including cancers.

Why it matters

Potential benefit: If successful, this research could lead to innovative therapies and diagnostic tools that respond to changes in the body, improving treatment outcomes for patients.

How similar studies have gone: While the study of oligonucleotides has shown promise, the specific approach of using intrinsically disordered proteins in nanoscale environments is relatively novel and less explored.

Where this research is happening

  • University of Massachusetts Lowell
    Lowell, United States
    Active

Researchers

  • Principal investigator: Ross, Michael B — University of Massachusetts Lowell
  • Study coordinator: Ross, Michael B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.